Program Description: 

ISTH Academy Webinar: Standardizing Bleeding History Using Bleeding Scores

Utility in Hemophilia – Stacy Croteau
This presentation will highlight the evolving clinical application of bleeding assessment tools in hemophilia. The utility and limitations of these tools in sub-groups including mild-moderate disease, severe disease, children and carriers are discussed.

 

Utility in Anticoagulated patients – Scott Kaatz
This presentation will discuss the diagnostic accuracy and clinical utility of bleed risk assessment models in anticoagulated patients.

 

Moderator: Suthesh Sivapalaratnam

 

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and International Society on Thrombosis and Haemostasis. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
 
Designation of Credit Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
More information and online registration:  http://academy.isth.org/ 
 

 


 
Target audience: 

Hematologists and other physicians that are involved in the initial and long-term care of patients diagnosed with bleeding disorders.

 

Learning objectives: 

At the end of this Webinar, the participants will be able to:

  1. Appreciate the differences in bleeding risk assessment models in anticoagulated patients with atrial fibrillation, venous thromboembolic disease.
  2. Be able to calculate bleeding risk for patients and mitigate modifiable risk factors.
  3. Describe the role of bleeding scores in the diagnosis and management of children and adults with hemophilia.
  4. Identify the limitations of bleeding assessment tools in current hemophilia care.
Faculty & credentials: 
Planning Committee:
Geoffrey Barnes, MD
Chris Ward, PhD
Stephen Watson, PhD

 

Speakers:
Stacy Croteau
Scott Kaatz
 
 
Moderator:
Suthesh Sivapalaratnam

All persons in control of content have NO relevant financial relationships to disclose with the exception of the following persons:  

 

 

Name

Company

Role

Geoffrey Barnes, MDBMS/Pfizer, Blue Cross Blue Shield of MI, AralezResearch Grant, Consulting
Chris Ward, PhDAlexian, Bayer, Boehringer Ingelheim, Roche, Pfizer/BMS, Sanofi-aventis, CSL, Janssen, AmgenSpeaker, Advisory Board, Sponsored attendee, Speaker, Project Supervisor
Stacy CroteauBaxalta/Shire, Bayer, Dimension Therapeutics, Emergent Bio Solutions, Novo Nordisk, Octapharma, PfizerConsultant, Advisory Board
Scott KaatzJanssen, Boehringer-Ingelheim, BMS, Pfizer, Daiichi Sankyo, CSL Behring, Portola,Speaker, Consultant, Research Funding, Board Membership
   

 
In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved

 

 

 

 

Contact

Name: 
Lacey Schmeidler, MA
Phone number: 
+1 (919) 929-3807
Email: 
[email protected]
Session date: 
01/18/2017 - 9:00am to 10:00am CST
Location: 
ISTH Webinar Library Once a Month
Carrboro, NC 27510
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.